Across TCGA pan-cancer cohorts, FAM86MP RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated FAM86MP data layer.
The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher FAM86MP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM86MP expression acts as an unfavorable survival marker, although some lineages such as THYM and STAD show a favorable association.
DLBC, ACC, and THCA are the cancer types where FAM86MP RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.